Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rebody Health vs ShedRx

Rebody Health
Graded #162

Lower grade

vs+19.299999999999997
ShedRx
Graded #3

Higher grade

The verdict

ShedRx takes it — 87/100 to 67.7/100.

ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread on the board — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueShedRx +38
46
84
Dose & formulationShedRx +8
88
96
Clinical oversightShedRx +3
81
84
Labs & monitoringShedRx +31
53
84
FulfillmentShedRx +4
84
88
Contract termsShedRx +30
55
85
Rebody Health · left barShedRx · right bar

The numbers

MetricRebody HealthShedRx
WeighScore67.7/10087/100
GradeCB+
Scorecard rank#162#3
Semaglutide$200/mo (starting dose, compounded)$199/mo
Tirzepatide$250/mo (starting dose, compounded)$299/mo
Coverage47 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
Rebody Health

Graded #162 · C

Strengths

  • Publishes transparent, dose-based pricing up front on a public pricing page, so you can see costs without signing up
  • Offers compounded semaglutide and tirzepatide as both weekly injections and daily oral 'melt' tablets
  • Also carries brand-name Wegovy and Zepbound for patients who want FDA-approved products
  • Clear plan-term vs dose-tier structure; the refill price is shown before each shipment, plus $50 off the first month
  • Names its operating company (Compound Technologies Inc.) and references LegitScript approval

Where it loses points

  • Individual compounding pharmacies are not named on the marketing site
  • Not available in Massachusetts, Rhode Island, or Vermont
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
  • Dose-scaled pricing means the monthly cost can rise as your prescribed dose increases
ShedRx

Graded #3 · B+

Strengths

  • Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
  • Brand Zepbound and Wegovy available beside the compounded line
  • Health coaching included with membership, plus a published 120-day weight-loss guarantee

Where it loses points

  • The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • The dispensing compounding pharmacy is not publicly named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard